Literature DB >> 9592628

Epidemiology of DSM-III-R major depression and minor depression among adolescents and young adults in the National Comorbidity Survey.

R C Kessler1, E E Walters.   

Abstract

Data on the prevalences, comorbidities, and cohort effects of DSM-III-R major depression (MD) and minor depression (mD) are reported for the nationally representative sample of n = 1,769 adolescents and young adults who participated in the National Comorbidity Survey. Lifetime prevalences are 15.3% (MD) and 9.9% (mD), while 30-day prevalences are 5.8% (MD) and 2.1% (mD). Most cases reported recurrent episodes (73.9% of those with MD and 69.2% with mD) and significant role impairment, including attempted suicide among 21.9% of those with MD. The majority of lifetime cases (76.7% of those with MD and 69.3% with mD) reported other comorbid lifetime NCS/ DSM-III-R disorders. Depression was temporally secondary in the majority of these cases. Number of prior disorders was more important than type of disorders in predicting subsequent depression, raising the possibility that secondary depression is a nonspecific severity marker for earlier disorders. A cohort effect for both MD and mD was documented that persisted even for episodes lasting a year or longer. Increasing prevalences of prior comorbid disorders were found to play an important part in explaining the cohort effect for depression.

Entities:  

Mesh:

Year:  1998        PMID: 9592628     DOI: 10.1002/(sici)1520-6394(1998)7:1<3::aid-da2>3.0.co;2-f

Source DB:  PubMed          Journal:  Depress Anxiety        ISSN: 1091-4269            Impact factor:   6.505


  204 in total

1.  Incidence of major depression in Canada.

Authors:  S B Patten
Journal:  CMAJ       Date:  2000-09-19       Impact factor: 8.262

Review 2.  Genetics of early onset bipolar affective disorder: are we making progress?

Authors:  Richard D Todd
Journal:  Curr Psychiatry Rep       Date:  2002-04       Impact factor: 5.285

3.  An outcome evaluation of the SOS Suicide Prevention Program.

Authors:  Robert H Aseltine; Robert DeMartino
Journal:  Am J Public Health       Date:  2004-03       Impact factor: 9.308

4.  Factors associated with mental health services use among disconnected African-American young adult population.

Authors:  Pallab K Maulik; Tamar Mendelson; S Darius Tandon
Journal:  J Behav Health Serv Res       Date:  2011-04       Impact factor: 1.505

5.  Open-label adjunctive creatine for female adolescents with SSRI-resistant major depressive disorder: a 31-phosphorus magnetic resonance spectroscopy study.

Authors:  Douglas G Kondo; Young-Hoon Sung; Tracy L Hellem; Kristen K Fiedler; Xianfeng Shi; Eun-Kee Jeong; Perry F Renshaw
Journal:  J Affect Disord       Date:  2011-08-09       Impact factor: 4.839

6.  Development and process evaluation of a primary care internet-based intervention to prevent depression in emerging adults.

Authors:  Benjamin W Van Voorhees; Justin M Ellis; Jackie K Gollan; Carl C Bell; Scott S Stuart; Joshua Fogel; Patrick W Corrigan; Daniel E Ford
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2007

7.  Influence of depressive symptoms on speech perception in adverse listening conditions.

Authors:  Bharath Chandrasekaran; Kristin Van Engen; Zilong Xie; Christopher G Beevers; W Todd Maddox
Journal:  Cogn Emot       Date:  2014-08-04

8.  Primary care patients with depression are less accepting of treatment than those seen by mental health specialists.

Authors:  Benjamin W Van Voorhees; Lisa A Cooper; Kathryn M Rost; Paul Nutting; Lisa V Rubenstein; Lisa Meredith; Nae-Yuh Wang; Daniel E Ford
Journal:  J Gen Intern Med       Date:  2003-12       Impact factor: 5.128

Review 9.  Role of estrogen in the aetiology and treatment of mood disorders.

Authors:  U Halbreich; L S Kahn
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

Review 10.  Evidence for the management of adolescent depression.

Authors:  R Eric Lewandowski; Mary C Acri; Kimberly E Hoagwood; Mark Olfson; Greg Clarke; William Gardner; Sarah Hudson Scholle; Sepheen Byron; Kelly Kelleher; Harold A Pincus; Samantha Frank; Sarah M Horwitz
Journal:  Pediatrics       Date:  2013-09-16       Impact factor: 7.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.